BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 915 filers reported holding BAXTER INTL INC in Q4 2013. The put-call ratio across all filers is 0.90 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $13,000 | +8.3% | 150 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $12,000 | -7.7% | 150 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $13,000 | 0.0% | 150 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $13,000 | +8.3% | 150 | 0.0% | 0.00% | +50.0% |
| Q2 2019 | $12,000 | +100.0% | 150 | +85.2% | 0.00% | +100.0% |
| Q1 2019 | $6,000 | -95.7% | 81 | -96.3% | 0.00% | -96.4% |
| Q1 2018 | $141,000 | -4.1% | 2,167 | -4.8% | 0.03% | +12.0% |
| Q4 2017 | $147,000 | -19.7% | 2,277 | -22.0% | 0.02% | -24.2% |
| Q3 2017 | $183,000 | -2.7% | 2,919 | -5.9% | 0.03% | -2.9% |
| Q2 2017 | $188,000 | +58.0% | 3,103 | +35.4% | 0.03% | +61.9% |
| Q1 2017 | $119,000 | +10.2% | 2,291 | -5.6% | 0.02% | -16.0% |
| Q4 2016 | $108,000 | +3500.0% | 2,427 | +3633.8% | 0.02% | +2400.0% |
| Q3 2016 | $3,000 | 0.0% | 65 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $3,000 | -57.1% | 65 | -59.6% | 0.00% | -66.7% |
| Q1 2016 | $7,000 | -86.3% | 161 | -77.9% | 0.00% | -83.3% |
| Q2 2015 | $51,000 | +70.0% | 730 | +69.4% | 0.02% | +50.0% |
| Q1 2015 | $30,000 | +42.9% | 431 | +52.3% | 0.01% | +33.3% |
| Q4 2014 | $21,000 | -70.8% | 283 | -63.9% | 0.01% | -74.3% |
| Q3 2014 | $72,000 | +260.0% | 783 | +176.7% | 0.04% | +250.0% |
| Q2 2014 | $20,000 | -39.4% | 283 | -43.4% | 0.01% | -52.4% |
| Q3 2013 | $33,000 | -5.7% | 500 | 0.0% | 0.02% | -19.2% |
| Q2 2013 | $35,000 | – | 500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
| SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
| Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
| Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
| HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
| Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
| 13D Management LLC | 200,318 | $14,791,000 | 3.77% |
| ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
| Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |